Characterization of chimeric proteins constructed from human epidermal growth factor (EGF) and the Drosophila EGF-receptor antagonist argos

  • Authors:
    • M Lohmeyer
    • S Mason
    • W Gullick
  • View Affiliations

  • Published online on: April 1, 1997     https://doi.org/10.3892/ijo.10.4.677
  • Pages: 677-682
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The Drosophila argos protein is a natural ligand antagonist of Drosophila EGF receptor (DER), but does not interact with the human EGF receptor (EGFR). With a view to generating a corresponding EGFR antagonist, we, have designed five chimeric proteins featuring selected characteristic parts of argos within the framework of the human EGF ligand. These chimeras were expressed in bacteria, purified, refolded and characterized. We tested their ability to bind to EC;FR, to effect receptor tyrosine phosphorylation and to inhibit EGF-induced EGFR phosphorylation.

Related Articles

Journal Cover

April 1997
Volume 10 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lohmeyer M, Mason S and Gullick W: Characterization of chimeric proteins constructed from human epidermal growth factor (EGF) and the Drosophila EGF-receptor antagonist argos. Int J Oncol 10: 677-682, 1997
APA
Lohmeyer, M., Mason, S., & Gullick, W. (1997). Characterization of chimeric proteins constructed from human epidermal growth factor (EGF) and the Drosophila EGF-receptor antagonist argos. International Journal of Oncology, 10, 677-682. https://doi.org/10.3892/ijo.10.4.677
MLA
Lohmeyer, M., Mason, S., Gullick, W."Characterization of chimeric proteins constructed from human epidermal growth factor (EGF) and the Drosophila EGF-receptor antagonist argos". International Journal of Oncology 10.4 (1997): 677-682.
Chicago
Lohmeyer, M., Mason, S., Gullick, W."Characterization of chimeric proteins constructed from human epidermal growth factor (EGF) and the Drosophila EGF-receptor antagonist argos". International Journal of Oncology 10, no. 4 (1997): 677-682. https://doi.org/10.3892/ijo.10.4.677